ALS patients get access to experimental sugar treatment
Disease control
NO_LONGER_AVAILABLE
This program gives intravenous trehalose to adults with ALS who cannot join other clinical trials. Trehalose is a sugar that may help slow disease progression. The goal is to provide treatment access, not to cure the disease.
Sponsor: Seelos Therapeutics, Inc. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC